Chemical Ind C05

Original report: PDF p. 35 ↗ PDF p. 36 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 35 ↗ PDF p. 36 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 38 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 38 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 39 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 39 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 40 ↗ PDF p. 41 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 75 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 75 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 66 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 66 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 36 ↗ PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 36 ↗ PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 38 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 39 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 40 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 41 ↗ PDF p. 42 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 73 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 73 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 74 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 74 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 36 ↗ PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 36 ↗ PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 36 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 38 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 39 ↗ PDF p. 40 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 35 ↗ PDF p. 36 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 35 ↗ PDF p. 36 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 38 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 39 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 40 ↗ PDF p. 41 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 34 ↗ PDF p. 35 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 34 ↗ PDF p. 35 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 36 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 37 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 38 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 39 ↗ PDF p. 40 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 45 ↗ PDF p. 46 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.

Original report: PDF p. 43 ↗

Five full primary-statement years ended 31 March 2022–2026. Monetary amounts are Singapore dollars thousands; EPS and the per-share summary are Singapore cents. Group and Company have separate balance sheets and changes in equity; separate Company income and cash-flow primary statements are not disclosed.

FY2025 Note 30 corrects a prior-period error for land restoration obligations at 3 Jalan Samulun and 91 Sakra Avenue. Full FY2024 comparatives and 1 April 2023 balance sheets are restated. All six FY2024 original primary tables are retained. The FY2023 and FY2022 full income, equity and cash-flow statements remain on their original disclosed basis; only the latest five-year summary discloses their restated performance. No undisclosed full restated statement is reconstructed.

The five-year summary gives FY2023 pretax/profit 3,753/3,217 and FY2022 5,503/6,470, versus original full statements 4,066/3,554 and 5,811/6,800. The FY2023 restated 1 April 2023 balance sheet is dated explicitly; original-basis FY2023 equity does not tie to this later restated balance sheet. These bases must not be mixed.

FY2022 cash flows were re-presented in the FY2023 comparative: inventory write-down 20 is separately added, working-capital inventories change by (20), foreign-exchange adjustment changes by (29), operating cash becomes 6,065 instead of 6,094, net cash 3,204 instead of 3,233, and a separate FX rollforward 29 is added. Closing cash remains 44,977. Original FY2022 cash flows are retained.

The original FY2022 Group equity current-year comprehensive Total prints share capital 75,945 alongside reserves (7), profit 6,800 and total 6,793. This printed capital cell does not sum or roll forward; the FY2023 comparative prints a dash. The original FY2022 equity table is retained without correcting the printed amount.

FY2025 also separates FY2024 net other income: original fair-value gain 9,800 plus Others (net) 1,593 becomes Other income 12,440 and Other expenses (1,365); the 1,047 foreign-exchange/disposal/FVTPL losses are separated from income and the 318 onerous provision is moved from administration. These classification changes are separate from the 317 pretax land-restoration correction. Original Note 22 and comparative Note 22 reconcile the components.

FY2025 cash-flow physical page 42 labels the financing subtotal as Net cash from (used in) investing activities, with values 3,075/(1,080). Its placement beneath Financing activities and the next annual comparative identify the subtotal; the original caption is retained.

The FY2026 five-year summary FY2022 total assets 153,292 differs by 1 from total liabilities 29,577 plus total equity 123,714. The printed FY2022 liability components sum to 29,578, also 1 above the printed total 29,577. Original figures are retained. Summary non-current liabilities excludes the separately displayed deferred tax liability; combine both only when comparing with primary-statement non-current liabilities.

FY2026 dividends paid (379) are printed within operating cash flows. Summary Dividend (net) relates to the declared/proposed dividend for that financial year, not necessarily the cash paid during that year. Source classifications are retained.

EPS source denominators are 75,945,399 shares in FY2026 and 75,945,000 shares in earlier reports; each source basis is retained. The 29 July 2026 AGM minutes print prior-year 2025 record/payment dates; the original dividend notice specifies record 6 August 2026 and payment 17 August 2026 for the FY2026 0.5-cent dividend.

Company FY2025 Note 31 states a 38,000 advance was settled by new subsidiary shares after that year end; FY2026 subsidiary investment cost rises by 38,000 while advances fall to nil. This internal capitalisation is not an external Group acquisition or an invented cash outflow.